Loading viewer...
earnings
Format: PDF earnings
Moderna presented first quarter 2024 financial results and business update on May 2, 2024, including RSV vaccine commercialization plans, 2024 financial guidance, and pipeline milestones. The earnings presentation outlined anticipated product sales, competitive positioning, and clinical development progress for multiple mRNA programs.
earnings
50 Pages
Unknown
Marathon Oil Q4 2016 Earnings Financial Operational Review
earningsearnings
23 Pages
Marathon Oil Corporation